APVO Aptevo Therapeutics Inc.
Fundamentals / CIK 0001671584 / USDAptevo Therapeutics Inc. reported $13.36M in total assets and a net loss of $25.41M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APVO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$25.89M Operating profit
-
Net Income FY 2025-$25.41M GAAP bottom line
-
Diluted EPS FY 2025-$14.11 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$8.27M Total debt: $3.99M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $3.11M | $12.29M | $4.31M | $32.42M | $23.07M | $14.66M | $9.98M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $19.93M | $11.21M | $5.01M | $12.47M |
| Gross Profit | -- | -- | -- | -- | -- | -- | $12.50M | $11.85M | $9.65M | -$2.48M |
| Research & Development | $14.54M | $14.38M | $17.11M | $17.88M | $18.99M | $17.85M | $24.76M | $35.38M | $29.02M | $29.12M |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | $25.34M | $28.13M | $34.58M | $36.16M |
| Operating Income | -$26.31M | -$24.60M | -$28.88M | -$28.64M | -$21.40M | -$27.49M | -$40.96M | -$51.66M | -$53.95M | -$138.8M |
| EBITDA | -$26.07M | -$24.25M | -$28.31M | -$27.74M | -$20.26M | -$26.09M | -$38.73M | -$49.27M | -$50.82M | -$135.4M |
| Income Before Tax | -$25.97M | -$24.13M | -$18.65M | $7.01M | -$29.41M | -$30.92M | -$43.06M | -$53.69M | -$55.89M | -$139.6M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- | -$23.30M | -$19.69M |
| Net Income | -$25.97M | -$24.13M | -$17.41M | $8.03M | -$28.46M | -$17.75M | -$40.45M | -$53.69M | $6.97M | -$112.4M |
| Basic EPS | -$78,480.22 | -$28,291,573.74 | -$6,561,729,074,790,055.00 | $544,120,917,006,581,760,000.00 | -$2,103,703,163,203,790,569,472.00 | -$1,812,581,143,913,645,211,648.00 | -$4,803,513,318,287,403,384,832.00 | -$11,666,358,586,576,927,195,136.00 | $1,610,836,122,832,797,696,000.00 | -$27,091,334,793,097,048,489,984.00 |
| Diluted EPS | -$78,480.22 | -$28,291,573.74 | -$6,561,729,074,790,055.00 | $544,120,917,006,581,760,000.00 | -$2,103,703,163,203,790,569,472.00 | -$1,812,581,143,913,645,211,648.00 | -$4,803,513,318,287,403,384,832.00 | -$11,666,358,586,576,927,195,136.00 | $1,610,836,122,832,797,696,000.00 | -$27,091,334,793,097,048,489,984.00 |
| Basic Shares Outstanding | 351 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 351 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $3.74M | $3.70M | $3.92M | $3.54M | $4.04M | $3.33M | $3.63M | $3.88M |
| Operating Income | -$6.61M | -$6.44M | -$6.84M | -$6.00M | -$7.61M | -$6.23M | -$6.48M | -$6.38M |
| EBITDA | -$6.58M | -$6.41M | -$6.80M | -$5.92M | -$7.56M | -$6.18M | -$6.42M | -$6.31M |
| Net Income | -$6.55M | -$6.36M | -$6.70M | -$5.81M | -$7.55M | -$6.20M | -$6.41M | -$6.31M |
| Basic EPS | -$5.19 | -$5.31 | -$5,764.39 | -- | -$40.13 | -$151.29 | -$1,422,491.01 | -- |
| Diluted EPS | -$5.19 | -$5.31 | -$5,764.39 | -- | -$40.13 | -$151.29 | -$1,422,491.01 | -- |
| Basic Shares Outstanding | 1.8M | 1.2M | 1.2K | -- | 224.9K | 41.0K | 5 | -- |
| Diluted Shares Outstanding | 1.8M | 1.2M | 1.2K | -- | 224.9K | 41.0K | 5 | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $21.62M | $8.71M | $16.90M | $22.64M | $45.04M | $39.98M | $12.45M | $30.64M | $7.09M | $9.68M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | $73.69M | $44.85M |
| Cash & Short-Term Investments | $21.62M | $8.71M | $16.90M | $22.64M | $45.04M | $39.98M | $12.45M | $30.64M | $80.78M | $54.52M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $7.02M | $5.22M | $2.14M | $307K |
| Inventory | -- | -- | -- | -- | -- | -- | $6.14M | $1.78M | $1.03M | $461K |
| Other Current Assets | $853K | $1.02M | $689K | $744K | $780K | $133K | $160K | $4.14M | $6.71M | $2.03M |
| Total Current Assets | $23.08M | $10.66M | $19.07M | $27.45M | $52.57M | $47.26M | $30.00M | $48.69M | $95.08M | $71.41M |
| Property, Plant & Equipment, Net | $303K | $543K | $895K | $1.46M | $2.38M | $2.81M | $3.95M | $5.20M | $5.84M | $5.91M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $4.42M | $5.25M | $6.08M | $6.91M |
| Other Non-Current Assets | -- | -- | -- | -- | $68K | $746K | $757K | $905K | -- | -- |
| Total Non-Current Assets | $4.11M | $4.93M | $5.78M | $6.76M | $4.03M | $6.28M | $23.41M | $18.80M | $21.92M | $20.44M |
| Total Assets | $27.19M | $15.59M | $24.84M | $34.22M | $56.60M | $53.55M | $53.41M | $67.49M | $117.0M | $91.86M |
| Accounts Payable | $877K | $1.24M | -- | -- | -- | -- | $6.43M | $11.67M | -- | -- |
| Short-Term Debt | -- | -- | -- | $2.00M | $11.67M | $5.00M | $19.86M | -- | $3.33M | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $811K |
| Other Current Liabilities | -- | $1.30M | $1.14M | $1.10M | $2.09M | $1.20M | $944K | $796K | $2.58M | $278K |
| Total Current Liabilities | $6.05M | $6.21M | $7.22M | $8.71M | $34.76M | $14.54M | $38.24M | $17.61M | $18.51M | $19.54M |
| Long-Term Debt | -- | -- | $0 | $1.46M | $3.71M | $23.22M | -- | $19.28M | $15.73M | $18.38M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.90M |
| Other Non-Current Liabilities | -- | $0 | -- | -- | -- | -- | -- | $200K | $734K | $469K |
| Total Non-Current Liabilities | $3.76M | $4.63M | $5.40M | $7.54M | $20.63M | $22.41M | $3.33M | $19.48M | $16.46M | $21.75M |
| Total Liabilities | $9.81M | $10.84M | $12.62M | $16.24M | $55.38M | $36.95M | $41.57M | $37.09M | $34.97M | $41.29M |
| Total Debt (incl. Leases) | $4.63M | $5.40M | $6.08M | $9.92M | $17.71M | $30.58M | $24.12M | $19.28M | $19.06M | $18.38M |
| Common Stock | $114K | $84K | $61K | $48K | $47K | $46K | $45K | $23K | $22K | $20K |
| Retained Earnings | -$275.1M | -$247.6M | -$223.4M | -$206.0M | -$214.1M | -$185.6M | -$167.9M | -$127.4M | -$73.72M | -$80.69M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | -- | -$105K | -$33K |
| Total Stockholders' Equity | $17.38M | $4.75M | $12.22M | $17.97M | $1.22M | $16.59M | $11.84M | $30.41M | $82.03M | $50.57M |
| Total Equity | $17.38M | $4.75M | $12.22M | $17.97M | $1.22M | $16.59M | $11.84M | $30.41M | $82.03M | $50.57M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.27M | $9.80M | $14.53M | $21.62M | $9.41M | $9.41M | $2.14M | $8.71M |
| Cash & Short-Term Investments | $8.27M | $9.80M | $14.53M | $21.62M | $9.41M | $9.41M | $2.14M | $8.71M |
| Other Current Assets | $967K | $462K | $851K | $853K | $77K | $82K | $120K | $1.02M |
| Total Current Assets | $9.70M | $10.80M | $15.98M | $23.08M | $22.65M | $11.08M | $3.61M | $10.66M |
| Property, Plant & Equipment, Net | $353K | $236K | $268K | $303K | $384K | $432K | $482K | $543K |
| Total Non-Current Assets | $3.67M | $3.72M | $3.92M | $4.11M | $4.35M | $4.54M | $4.74M | $4.93M |
| Total Assets | $13.36M | $14.52M | $19.90M | $27.19M | $27.00M | $15.62M | $8.34M | $15.59M |
| Accounts Payable | $1.48M | $1.16M | $890K | $877K | -- | -- | -- | $1.24M |
| Other Current Liabilities | -- | -- | -- | -- | $1.49M | $948K | $1.13M | $1.30M |
| Total Current Liabilities | $6.46M | $5.19M | $4.76M | $6.05M | $5.61M | $4.89M | $5.39M | $6.21M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $3.04M | $3.29M | $3.53M | $3.76M | $3.99M | $4.21M | $4.42M | $4.63M |
| Total Liabilities | $9.50M | $8.48M | $8.29M | $9.81M | $9.60M | $9.10M | $9.81M | $10.84M |
| Total Debt (incl. Leases) | $3.99M | $4.21M | $4.42M | $4.63M | $4.80M | $5.00M | $5.20M | $5.40M |
| Common Stock | $115K | $114K | $114K | $114K | $110K | $99K | $84K | $84K |
| Retained Earnings | -$297.6M | -$288.3M | -$281.9M | -$275.1M | -$269.2M | -$260.2M | -$254.0M | -$247.6M |
| Total Stockholders' Equity | $3.86M | $6.04M | $11.61M | $17.38M | $17.39M | $6.52M | -$1.47M | $4.75M |
| Total Equity | $3.86M | $6.04M | $11.61M | $17.38M | $17.39M | $6.52M | -$1.47M | $4.75M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$25.97M | -$24.13M | -$17.41M | $8.03M | -$28.46M | -$17.75M | -$40.45M | -$53.69M | $6.97M | -$112.4M |
| Depreciation & Amortization | $240K | $352K | $567K | $901K | $1.14M | $1.41M | $2.23M | $2.39M | $3.13M | $3.36M |
| Stock-Based Compensation | $96K | $1.07M | $2.19M | $1.80M | $1.64M | $1.25M | $1.60M | $2.14M | $4.88M | $3.81M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -$1.80M | -$3.08M | -$1.83M | $2.17M |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -$4.35M | -$757K | -$567K | $13.68M |
| Operating Cash Flow | -$25.59M | -$23.79M | -$11.73M | -$21.02M | -$21.68M | -$29.32M | -$42.38M | -$51.42M | -$41.57M | -$36.86M |
| Capital Expenditure | -- | -- | -- | -$29K | -$713K | -$88K | -$153K | -$976K | -$1.40M | -$2.51M |
| Free Cash Flow | -- | -- | -- | -$21.05M | -$22.39M | -$29.41M | -$42.54M | -$52.40M | -$42.98M | -$39.37M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -$16.54M | -$99.63M | -$44.88M |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | $90.24M | $70.73M | -- |
| Investing Cash Flow | $0 | $0 | $0 | -$29K | -$713K | $28.03M | $4.10M | $72.80M | $29.46M | -$47.39M |
| Common Stock Issued | $37.94M | $10.04M | $6.43M | $6.93M | $10.23M | -- | -- | $623K | $442K | -- |
| Financing Cash Flow | $38.50M | $15.60M | $6.00M | -$2.62M | $26.16M | $23.87M | $20.15M | -$787K | $19.53M | $89.30M |
| Net Change in Cash | $12.90M | -$8.19M | -$5.73M | -$23.67M | $3.77M | $22.59M | -$18.14M | $20.59M | $7.42M | $5.04M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.55M | -$6.36M | -$6.70M | -$5.81M | -$7.55M | -$6.20M | -$6.41M | -$6.31M |
| Depreciation & Amortization | $39K | $32K | $35K | $81K | $49K | $49K | $61K | $71K |
| Stock-Based Compensation | $51K | $58K | $57K | $2.0K | $77K | -$163K | $180K | -$72K |
| Change in Payables | $315K | $272K | $13K | -- | $267K | -$936K | $278K | -- |
| Operating Cash Flow | -$5.69M | -$5.45M | -$7.96M | -$5.24M | -$6.69M | -$7.09M | -$6.58M | -$5.76M |
| Investing Cash Flow | -$156K | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| Common Stock Issued | $4.32M | $726K | $872K | $5.24M | $18.34M | $14.36M | $0 | -- |
| Financing Cash Flow | $4.32M | $726K | $871K | $5.79M | $18.34M | $14.36M | $0 | $6.72M |
| Net Change in Cash | -$1.53M | -$4.73M | -$7.09M | $558K | $11.65M | $7.27M | -$6.58M | $961K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | 38.5% | 51.4% | 65.8% | -24.9% |
| Operating Margin | -- | -- | -- | -919.7% | -174.1% | -638.1% | -126.3% | -224.0% | -368.1% | -1389.8% |
| Net Profit Margin | -- | -- | -- | 257.8% | -231.5% | -411.9% | -124.7% | -232.8% | 47.6% | -1125.8% |
| Return on Equity (ROE) | -149.4% | -507.5% | -142.5% | 44.7% | -2340.2% | -107.0% | -341.6% | -176.6% | 8.5% | -222.3% |
| Return on Assets (ROA) | -95.5% | -154.8% | -70.1% | 23.5% | -50.3% | -33.1% | -75.7% | -79.5% | 6.0% | -122.4% |
| Current Ratio | 3.82x | 1.72x | 2.64x | 3.15x | 1.51x | 3.25x | 0.78x | 2.76x | 5.14x | 3.65x |
| Quick Ratio | 3.57x | 1.40x | 2.34x | 2.60x | 1.30x | 2.75x | 0.62x | 2.66x | 5.08x | 3.63x |
| Debt to Equity | 0.27x | 1.14x | 0.50x | 0.55x | 14.57x | 1.84x | 2.04x | 0.63x | 0.23x | 0.36x |
| Revenue Growth (YoY) | -- | -- | -- | -74.7% | +185.3% | -86.7% | +40.6% | +57.4% | +46.8% | -70.3% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | +5.4% | +22.9% | -- | -114.9% |
| Net Income Growth (YoY) | -- | -- | -316.9% | -- | -- | -- | -- | -870.0% | -- | -- |
| EPS Growth (YoY) | -- | -- | -100.0% | -- | -- | -- | -- | -824.2% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -658.1% | -437.1% | -226.1% | -149.4% | -152.2% | -368.3% | -- | -507.5% |
| Return on Assets (ROA) | -190.1% | -181.9% | -131.9% | -95.5% | -98.1% | -153.8% | -284.2% | -154.8% |
| Current Ratio | 1.50x | 2.08x | 3.36x | 3.82x | 4.03x | 2.27x | 0.67x | 1.72x |
| Quick Ratio | 1.28x | 1.89x | 3.05x | 3.57x | 1.68x | 1.92x | 0.40x | 1.40x |
| Debt to Equity | 1.03x | 0.70x | 0.38x | 0.27x | 0.28x | 0.77x | -- | 1.14x |